Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy M Pérez-Martelo, A González-García, Y Vidal-Ínsua, C Blanco-Freire, ... Scientific Reports 12 (1), 6893, 2022 | 10 | 2022 |
MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles M Santamarina-García, J Brea-Iglesias, JB Bramsen, M Fuentes-Losada, ... Iscience 26 (3), 2023 | 1 | 2023 |
Clinical outcomes of immunotherapy-based first-line regimens in advanced Renal Cell Carcinoma–the Onco-CHUS experience UA Herranz, N Fernandez-Diaz, J Garcia-Gonzalez, V Cebey-Lopez, ... European Urology Open Science 57, S233, 2023 | | 2023 |
Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the … M Ferreiro-Pantín, U Anido-Herranz, YZ Betancor, V Cebey-López, ... ESMO open 8 (4), 101611, 2023 | | 2023 |
Use of immunotherapy-based combos in advanced renal cell carcinoma in a Galician center. U Anido, J García González, V Cebey, M Mateos González, M Touris, ... Journal of Clinical Oncology 41 (16_suppl), e16542-e16542, 2023 | | 2023 |
A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma YZ Betancor, M Ferreiro-Pantin, U Anido-Herranz, M Fuentes-Losada, ... medRxiv, 2023.12. 03.23299342, 2023 | | 2023 |